US Covid-19 Vaccine Market - Forecast(2024 - 2030)

1. Covid-19 Vaccine Production

    1.1. Covid-19 Vaccine Production in the US (Million Doses) 2021

    1.2. Covid-19 Vaccine Production Growth Rate (%) in the US (Million Doses) 2021

    1.3. Covid-19 Vaccine Monthly Production in the US (Million Doses) 2021

    1.4. Covid-19 Vaccine Monthly Production Growth Rate (%) in the US 2021

    1.5. COVID-19 vaccine production by manufacturers (Million Doses) 2021

2. Covid-19 Vaccine Price by country

3. Covid-19 Vaccine Composition

4. Covid-19 Percentage of Vaccination Completed by Country

    4.1. Covid-19 At Least One Dose Vaccination in the US 2021-2022

    4.2. Covid-19 Fully Vaccinated Doses in the US 2021-2022

    4.3. Covid-19 Booster Dose Eligible Count in the US 2021-2022

    4.4. Covid-19 Booster Dose Count in the US 2021-2022

    4.5. Percentage of Covid-19 Vaccination-Single Dose/Fully Vaccination in the US 2021-2022

    4.6. Percentage of Covid-19 Vaccination-Booster Dose Eligible /Booster in the US 2021-2022

5. Investments on Covid-19 vaccine by country

    5.1. US Covid-19 Supplemental funding by five congressional acts in Million USD

    5.2. Major Funding jurisdiction for Covid-19 in the US by American Rescue Plan Act of 2021

    5.3. Major Funding jurisdiction for Covid-19 in the US by Coronavirus Aid, Relief, and Economic Security Act

    5.4. Major Funding jurisdiction for Covid-19 in the US by Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020

    5.5. Major Funding jurisdiction for Covid-19 in the US by Coronavirus Aid, Relief, and Economic Security Act/5

    5.6. Major Funding jurisdiction for Covid-19 in the US by Coronavirus Response and Relief Supplemental Appropriations Act, 2021

    5.7. Major Funding jurisdiction for Covid-19 in the US by Paycheck Protection Program and Health Care Enhancement Act

6. Imported and exported vaccines Count from 2020-2022

    6.1. Major Recipients of U.S. Covid-19 Vaccine Donation Deliveries by Total Doses Received

    6.2. U.S. Covid-19 Vaccine Donation Deliveries by Region

    6.3. U.S. Covid-19 Vaccine Donation Doses Delivered by Vaccine Product

    6.4. U.S. Covid-19 Vaccine Donation Doses Delivered by Vaccine Product

    6.5. U.S. Covid-19 Vaccine Donation Deliveries by Income

    6.6. U.S. Covid-19 Vaccine Dose Donations Pledged that Have Been Shipped and Delivered

    6.7. Imported Percentage change of trade in medical goods in the first half of 2019

    6.8. Imported Percentage change of trade in medical goods in the first half of 2020

    6.9. Imported Percentage change of trade in medical goods Growth Rate (%) in the 2019-2020

    6.10. Bilateral trade statistics on COVID-19-critical products Value of imports for the first half of the year 2019

    6.11. Bilateral trade statistics on COVID-19-critical products Value of imports for the first half of the year 2020

    6.12. Bilateral trade statistics on COVID-19-critical products Growth Rate (%) 2019-2020

    6.13. US value in importing face masks from China during the first half of 2020

    6.14. US value in importing face masks from China in Percentage 2020 

    6.15. World's Top Exporters of Covid-19 Critical Products during the first half of 2020

    6.16. World's Top Exporters of Covid-19 Critical Products Growth Rate (%) during the first half of 2020

    6.17. Share (%) of World's Top Exporters of Covid-19 Critical Products during the first half of 2020

    6.18. World's Top Importers of Covid-19 Critical Products during the first half of 2020

    6.19. World's Top Importers of Covid-19 Critical Products Growth Rate (%) during the first half of 2020

    6.20. Share (%) of World's Top Importers of Covid-19 Critical Products during the first half of 2020

7. Covid-19 Total no of cases by country

    7.1. Covid-19 Confirmed Cases in the US 2020 

    7.2. Covid-19 Confirmed Cases Growth Rate (%) in the US 2020

    7.3. Covid-19 Confirmed Cases in the US 2021-2022 

    7.4. Covid-19 Confirmed Cases Growth Rate (%) in the US 2021-2022

    7.5. Covid-19 reported cases in the US (2020-2022)

    7.6. Covid-19 Reported Cases Growth Rate (%) in the US  2020-2022

8. Covid-19 Prevalence of disease

    8.1. Covid-19 Cases Prevalence Rate (%) in the US 2020-2022

9. Covid-19 testing kits

    9.1. Covid-19 Tests and Collection Kits Authorized by the FDA-2020

    9.2. Covid-19 Tests and Collection Kits Authorized by the FDA-2021

    9.3. Covid-19 Tests and Collection Kits Growth Rate (%) in the US 2021

10. Covid-19 Comorbidity rate

    10.1. Major Comorbidity Conditions Contributing to COVID-19 Deaths, in the US 2020

    10.2. Major Comorbidity Conditions Contributing to Covid-19 Deaths, in the US 2021

    10.3. Major Comorbidity Conditions Contributing to Covid-19 Deaths, in the US 2022

    10.4. Major Comorbidity Conditions Contributing to Covid-19 Deaths, in the US 2020-2021

    10.5. Major Comorbidity Conditions Growth rate (%) Contributing to COVID-19 Deaths, in the US 2020-2021

11. Covid-19 Mortality rate by age group By Country

    11.1. Covid-19 Male Mortality Rate by Age in the US-2020

    11.2. Covid-19 Female Mortality Rate by Age in the US-2020

    11.3. Covid-19 Male Mortality Rate by Age in the US-2021

    11.4. Covid-19 Female Mortality Rate by Age in the US-2021

    11.5. Covid-19 Mortality Rate by Age in the US-2022

    11.6. Covid-19 Reported Deaths in the US  2020

    11.7. Covid-19 Death Cases Growth Rate (%) in the US 2020

    11.8. Covid-19 Reported Deaths in the US (2021-2022)

    11.9.  Covid-19 Death Cases Growth Rate (%) in the US  2021-2022

    11.10. Covid-19 Reported Cases and Death Cases (2020-2022)

    11.11. Covid-19 Fatality Rate in Percentage (%) in the US 2020

    11.12. Covid-19 Fatality Rate in Percentage (%) in the US 2021-2022

12. GDP Contribution of Covid-19 Vaccines

    12.1. Covid-19 Effect on Gross Domestic Product GDP Rate (%) in the US 2020

    12.2. Covid-19 Effect on Gross Domestic Product GDP Rate (%) in the US 2021

13. Clinical trial data of Covid-19

    13.1. No. of Clinical trials of Covid-19 in the US (2019-2022)

    13.2. No. of Clinical trials of Covid-19 in the US in Phases (2019-2022)

    13.3. Percentage of Clinical trials of Covid-19 in the US by Age (2019-2022)

    13.4. Percentage of Clinical trials of Covid-19 in the US by Gender (2019-2022)

    13.5. No. of Clinical trials of Covid-19 in the US by Funding Type (2019-2022)

    13.6. No. of Clinical trials of Covid-19 in the US by Status (2019-2022)

    13.7. No. of Clinical trials of Covid-19 in the US by Study Type (2019-2022)

    13.8. No. of Clinical trials of Covid-19 in the US by Study Documents (2019-2022)

14. Patents

    14.1. Covid-19 Patents Documented in the US (2020)

    14.2. Covid-19 Patents Documented in the US (2021)

    14.3. Covid-19 Patents Documented in the US (2022)

    14.4. Covid-19 Patent documents by Published, Filed and Granted Date in the US (2020)

    14.5. Covid-19 Patent documents by Published, Filed and Granted Date in the US (2021)

    14.6. Covid-19 Patent documents by Type in the US by Study (2020)

    14.7. Covid-19 Patent documents by Type in the US by Study (2021)

    14.8. Covid-19 Patent documents by Type in the US by Study (2022)

    14.9. Covid-19 Patent Legal Status in the US (2020)

    14.10. Covid-19 Patent Legal Status in the US (2021)

    14.11. Major Applicants of Covid-19 in the US (2020)

    14.12. Major Applicants of Covid-19 in the US (2021)

    14.13. Major Applicants of Covid-19 in the US (2022)

    14.14. Covid-19 Top Owners in the US by Study (2020)

    14.15. Covid-19 Top Owners in the US by Study (2021)

    14.16. Covid-19 Top Owners in the US by Study (2022)

15. Covid-19 Major Vaccine Brands in the US

16. Covid-19 Vaccine supply agreements in the US